Screening for Colorectal Cancer.
Ann Intern Med
; 177(4): ITC49-ITC64, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-38588547
ABSTRACT
Colorectal cancer (CRC) is the second leading cause of cancer death. Screening has been proven to reduce both cancer incidence and cancer-related mortality. Various screening tests are available, each with their own advantages and disadvantages and varying levels of evidence to support their use. Clinicians should offer CRC screening to average-risk persons aged 50 to 75 years; starting screening at age 45 years remains controversial. Screening may be beneficial in select persons aged 76 to 85 years, based on their overall health and screening history. Offering a choice of screening tests or sequentially offering an alternate test for those who do not complete screening can significantly increase participation.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Colorrectales
/
Detección Precoz del Cáncer
Límite:
Humans
/
Middle aged
Idioma:
En
Revista:
Ann Intern Med
Año:
2024
Tipo del documento:
Article